Anne S. Renteria, MD, has joined our Hematology Oncology team as Medical Director, Acute Leukemia & Stem Cell Transplant and Cellular Therapy Programs. Dr. Renteria will lead the Lipson Cancer Institute’s Acute Leukemia Program and drive the development of our groundbreaking new Stem Cell Transplant and Cellular Therapy Program.
A distinguished practicing physician for more than 20 years, Dr. Renteria previously served as Medical Director of Hematology Oncology & Cellular and Gene Therapies at ICON Clinical Research, in New York, NY. ICON Plc is a global provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries.
Dr. Renteria’s primary areas of focus are hematologic malignancies and stem cell transplantation. She earned her MD degree from Brazil’s Federal University of Rio de Janeiro, and completed a residency in Internal Medicine at Coney Island Hospital in Brooklyn, NY. She also has completed fellowships in Hematology Oncology (Maimonides Medical Center) and Bone and Marrow Transplantation (Mount Sinai School of Medicine, NY). Dr. Renteria served as an attending physician at the Tisch Cancer Institute at Mount Sinai School of Medicine, where she also was an assistant professor of medicine. She also served as an attending physician and assistant professor at the Boston University School of Medicine, as well as principal or co-investigator in multiple clinical research trials. At ease in multiple cultural environments, Dr. Renteria holds a French baccalaureate and speaks English, Spanish, French, and Portuguese.
1425 Portland Ave
Rochester, NY 14621
1555 Long Pond Rd
Rochester, NY 14626
127 North St
Batavia, NY 14020
A recent congressional report has parents reeling after finding arsenic, lead and other toxic metals in several well-known brands of baby food. Experts say not to panic – but do make some changes for the future.Read Article
Addressing the need for immediate, around-the-clock behavioral health care access in the Rochester community has become a higher priority than ever before.Read Article